In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.
Read more here.
![[OncoHost in Jerusalem Post] Israeli algorithm may predict if cancer patients will respond to treatment](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[OncoHost in Jerusalem Post] Israeli algorithm may predict if cancer patients will respond to treatment
December 31, 2019
[Oxx in PR Newswire] Oxx Congratulates ForeScout on Positive First Results Following IPO
December 11, 2017
